Literature DB >> 1911180

Coagulation and cancer.

J C Murray.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1911180      PMCID: PMC1977669          DOI: 10.1038/bjc.1991.325

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  14 in total

1.  Thrombophlebitis and cancer.

Authors:  J S LIEBERMAN; J BORRERO; E URDANETA; I S WRIGHT
Journal:  JAMA       Date:  1961-08-26       Impact factor: 56.272

2.  Thromboplastic activity of leukemic white cells.

Authors:  G EISEMAN; M STEFANINI
Journal:  Proc Soc Exp Biol Med       Date:  1954 Aug-Sep

3.  Identification and partial purification of a novel tumor-derived protein that induces tissue factor on cultured human endothelial cells.

Authors:  M Noguchi; T Sakai; W Kisiel
Journal:  Biochem Biophys Res Commun       Date:  1989-04-14       Impact factor: 3.575

4.  Recombinant human tumor necrosis factor-alpha: thrombus formation is a cause of anti-tumor activity.

Authors:  K Shimomura; T Manda; S Mukumoto; K Kobayashi; K Nakano; J Mori
Journal:  Int J Cancer       Date:  1988-02-15       Impact factor: 7.396

5.  Toxic effect of tumor necrosis factor on tumor vasculature in mice.

Authors:  N Watanabe; Y Niitsu; H Umeno; H Kuriyama; H Neda; N Yamauchi; M Maeda; I Urushizaki
Journal:  Cancer Res       Date:  1988-04-15       Impact factor: 12.701

6.  Role of tumor necrosis factor in flavone acetic acid-induced tumor vasculature shutdown.

Authors:  V Mahadevan; S T Malik; A Meager; W Fiers; G P Lewis; I R Hart
Journal:  Cancer Res       Date:  1990-09-01       Impact factor: 12.701

7.  Potential role of interleukin-1 as the trigger for diffuse intravascular coagulation in acute nonlymphoblastic leukemia.

Authors:  F Cozzolino; M Torcia; A Miliani; A M Carossino; R Giordani; S Cinotti; E Filimberti; R Saccardi; P Bernabei; G Guidi
Journal:  Am J Med       Date:  1988-02       Impact factor: 4.965

8.  A polypeptide factor produced by fibrosarcoma cells that induces endothelial tissue factor and enhances the procoagulant response to tumor necrosis factor/cachectin.

Authors:  M Clauss; J C Murray; M Vianna; R de Waal; G Thurston; P Nawroth; H Gerlach; R Bach; P C Familletti; D Stern
Journal:  J Biol Chem       Date:  1990-04-25       Impact factor: 5.157

9.  Flavone acetic acid induces a coagulopathy in mice.

Authors:  J C Murray; K A Smith; G Thurston
Journal:  Br J Cancer       Date:  1989-11       Impact factor: 7.640

10.  Tumor necrosis factor/cachectin-induced intravascular fibrin formation in meth A fibrosarcomas.

Authors:  P Nawroth; D Handley; G Matsueda; R De Waal; H Gerlach; D Blohm; D Stern
Journal:  J Exp Med       Date:  1988-08-01       Impact factor: 14.307

View more
  8 in total

1.  Tissue factor and cancer procoagulant expressed by glioma cells participate in their thrombin-mediated proliferation.

Authors:  T Ogiichi; Y Hirashima; S Nakamura; S Endo; M Kurimoto; A Takaku
Journal:  J Neurooncol       Date:  2000       Impact factor: 4.130

2.  Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis.

Authors:  B M Mueller; R A Reisfeld; T S Edgington; W Ruf
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

3.  Coagulation tests show significant differences in patients with breast cancer.

Authors:  Faruk Tas; Leyla Kilic; Derya Duranyildiz
Journal:  Tumour Biol       Date:  2014-03-05

4.  Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice.

Authors:  Y Zhang; Y Deng; T Luther; M Müller; R Ziegler; R Waldherr; D M Stern; P P Nawroth
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

5.  Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer.

Authors:  Luc Y Dirix; R Salgado; R Weytjens; C Colpaert; I Benoy; P Huget; P van Dam; A Prové; J Lemmens; P Vermeulen
Journal:  Br J Cancer       Date:  2002-02-01       Impact factor: 7.640

6.  Gastrointestinal stromal tumors: Fibrinogen levels are associated with prognosis of patients as blood-based biomarker.

Authors:  Jing Lu; Shuangjiang Chen; Xuqi Li; Guanglin Qiu; Shicai He; Haijiang Wang; Libo Zhou; Yaheng Jing; Xiangming Che; Lin Fan
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

7.  Prognostic Significance of the Combination of Fibrinogen and Tumor Marker Index in Esophageal Squamous Cell Carcinoma Patients.

Authors:  Yufeng Qiao; Mingquan Ma; Hongdian Zhang; Zhentao Yu; Peng Tang
Journal:  Onco Targets Ther       Date:  2021-02-17       Impact factor: 4.147

8.  Elevated levels of plasma D-dimer predict a worse outcome in patients with nasopharyngeal carcinoma.

Authors:  Wen-Hui Chen; Lin-Quan Tang; Feng-Wei Wang; Chang-Peng Li; Xiao-Peng Tian; Xiao-Xia Huang; Shi-Juan Mai; Yi-Ji Liao; Hai-Xia Deng; Qiu-Yan Chen; Huai Liu; Lu Zhang; Shan-Shan Guo; Li-Ting Liu; Shu-Mei Yan; Chao-Feng Li; Jing-Ping Zhang; Qing Liu; Xue-Wen Liu; Li-Zhi Liu; Hai-Qiang Mai; Mu-Sheng Zeng; Dan Xie
Journal:  BMC Cancer       Date:  2014-08-10       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.